Ambulatory Blood Pressure Monitoring

William White

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

ACC 2023 Conference Coverage

J. Saseen

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Scripps Health

N. Lepor

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano